{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:15:27Z","timestamp":1789143327473,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117218","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:05:24Z","timestamp":1785542724000},"page":"117218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiac ACY1 ameliorates pathological hypertrophy by suppressing \u03b2-catenin\/TCF4 signaling"],"prefix":"10.1016","volume":"187","author":[{"given":"Yangxian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiannong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankang","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2026.117218_bb0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41569-022-00756-z","article-title":"Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure","volume":"20","author":"Kamel","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"15","key":"10.1016\/j.intimp.2026.117218_bb0010","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/CIRCULATIONAHA.119.045115","article-title":"High-resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy","volume":"142","author":"McLellan","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.intimp.2026.117218_bb0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41569-023-00887-x","article-title":"Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges","volume":"20","author":"Ritterhoff","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117218_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","article-title":"Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential","volume":"20","author":"Martin","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"14","key":"10.1016\/j.intimp.2026.117218_bb0025","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.121.055841","article-title":"Elevated MCU expression by CaMKII\u03b4B limits pathological cardiac remodeling","volume":"145","author":"Wang","year":"2022","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.intimp.2026.117218_bb0030","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/CIRCULATIONAHA.120.051094","article-title":"HINT1 (histidine triad nucleotide-binding protein 1) attenuates cardiac hypertrophy via suppressing HOXA5 (homeobox A5) expression","volume":"144","author":"Zhang","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.intimp.2026.117218_bb0035","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCULATIONAHA.121.054827","article-title":"Targeting E3 ubiquitin ligase WWP1 prevents cardiac hypertrophy through destabilizing DVL2 via inhibition of K27-linked ubiquitination","volume":"144","author":"Zhao","year":"2021","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.intimp.2026.117218_bb0040","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","article-title":"Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy","volume":"141","author":"Ren","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.intimp.2026.117218_bb0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41392-023-01660-9","article-title":"Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012\/9456","volume":"8","author":"Wan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2026.117218_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106989","article-title":"A novel co-target of ACY1 governing plasma membrane translocation of SphK1 contributes to inflammatory and neuropathic pain","volume":"26","author":"Liu","year":"2023","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.intimp.2026.117218_bb0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/cge.12297","article-title":"Aminoacylase I deficiency due to ACY1 mRNA exon skipping","volume":"86","author":"Ferri","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.intimp.2026.117218_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149123","article-title":"N-Acetylglutamate and N-acetylmethionine compromise mitochondrial bioenergetics homeostasis and glutamate oxidation in brain of developing rats: potential implications for the pathogenesis of ACY1 deficiency","volume":"684","author":"Bortoluzzi","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.intimp.2026.117218_bb0065","doi-asserted-by":"crossref","first-page":"17010","DOI":"10.1016\/S0021-9258(19)85294-8","article-title":"Human aminoacylase-1. Cloning, sequence, and expression analysis of a chromosome 3p21 gene inactivated in small cell lung cancer","volume":"268","author":"Cook","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.intimp.2026.117218_bb0070","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.3390\/cancers14225704","article-title":"ACY1 downregulation enhances the radiosensitivity of cetuximab-resistant colorectal cancer by inactivating the Wnt\/\u03b2-catenin signaling pathway","volume":"14","author":"Shan","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.intimp.2026.117218_bb0075","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41401-021-00830-1","article-title":"Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure","volume":"43","author":"Lai","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.intimp.2026.117218_bb0080","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.7150\/ijbs.83392","article-title":"Inhibition of KMO ameliorates myocardial ischemia injury via maintaining mitochondrial fusion and fission balance","volume":"19","author":"Lai","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2026.117218_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2023.06.001","article-title":"Inhibition of OAT1\/3 and CMPF uptake attenuates myocardial ischemia-induced chronic heart failure via decreasing fatty acid oxidation and the therapeutic effects of ruscogenin","volume":"261","author":"Lai","year":"2023","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.117218_bb0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2023.04.057","article-title":"Management of worsening heart failure with reduced ejection fraction: JACC focus seminar 3\/3","volume":"82","author":"Greene","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117218_bb0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11011-015-9778-6","article-title":"Expanding the phenotype in aminoacylase 1 (ACY1) deficiency: characterization of the molecular defect in a 63-year-old woman with generalized dystonia","volume":"31","author":"Sass","year":"2016","journal-title":"Metab. Brain Dis."},{"issue":"6","key":"10.1016\/j.intimp.2026.117218_bb0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbadis.2011.03.005","article-title":"The molecular basis of aminoacylase 1 deficiency","volume":"1812","author":"Sommer","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20133","key":"10.1016\/j.intimp.2026.117218_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.febslet.2004.04.093","article-title":"Aminoacylase 1 is a sphingosine kinase 1-interacting protein","volume":"568","author":"Maceyka","year":"2004","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.intimp.2026.117218_bb0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2014.05.001","article-title":"Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma","volume":"351","author":"Wei","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.117218_bb0115","article-title":"Aminoacylase 1 (ACY-1) mediates the proliferation and migration of neuroblastoma cells in humans through the ERK\/transforming growth factor \u03b2 (TGF-\u03b2) signaling pathways","volume":"27","author":"Chen","year":"2021","journal-title":"Med. Sci. Monit."},{"issue":"16","key":"10.1016\/j.intimp.2026.117218_bb0120","doi-asserted-by":"crossref","first-page":"eaax4826","DOI":"10.1126\/sciadv.aax4826","article-title":"The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor","volume":"6","author":"Bi","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.intimp.2026.117218_bb0125","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka","year":"2014","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.117218_bb0130","article-title":"The silencing transcription factor REST targets UCHL1 to regulate inflammatory response and fibrosis during cardiac hypertrophy","volume":"11","author":"Cao","year":"2023","journal-title":"Genes Dis."},{"issue":"10","key":"10.1016\/j.intimp.2026.117218_bb0135","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41440-020-0486-1","article-title":"Blockage of UCHL1 activity attenuates cardiac remodeling in spontaneously hypertensive rats","volume":"43","author":"Han","year":"2020","journal-title":"Hypertens. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117218_bb0140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIRCULATIONAHA.123.065304","article-title":"Deficiency of the deubiquitinase UCHL1 attenuates pulmonary arterial hypertension","volume":"150","author":"Tang","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.intimp.2026.117218_bb0145","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bbrc.2018.04.225","article-title":"Loss of P53 regresses cardiac remodeling induced by pressure overload partially through inhibiting HIF1\u03b1 signaling in mice","volume":"501","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2026.117218_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2012.10.051","article-title":"BACE1 levels are elevated in congestive heart failure","volume":"532","author":"Nural-Guvener","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.intimp.2026.117218_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCRESAHA.110.238717","article-title":"Endogenous muscle atrophy F-box mediates pressure overload induced cardiac hypertrophy through regulation of nuclear factor-kappa B","volume":"109","author":"Usui","year":"2011","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.117218_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003010","article-title":"Transcription factor 7-like 2 mediates canonical Wnt\/\u03b2-catenin signaling and c-Myc upregulation in heart failure","volume":"9","author":"Hou","year":"2016","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.intimp.2026.117218_bb0165","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00125-008-1004-1","article-title":"TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the atherosclerosis risk in communities (ARIC) study","volume":"51","author":"Bielinski","year":"2008","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.intimp.2026.117218_bb0170","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4093\/dmj.2020.0101","article-title":"Association of combined TCF7L2 and KCNQ1 gene polymorphisms with diabetic micro- and macrovascular complications in type 2 diabetes mellitus","volume":"45","author":"Rattanatham","year":"2021","journal-title":"Diabetes Metab. J."},{"issue":"6","key":"10.1016\/j.intimp.2026.117218_bb0175","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/nar\/gky049","article-title":"A context-specific cardiac \u03b2-catenin and GATA4 interaction influences TCF7L2 occupancy and remodels chromatin driving disease progression in the adult heart","volume":"46","author":"Iyer","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.117218_bb0180","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41374-019-0204-2","article-title":"Opposing roles of TCF7\/LEF1 and TCF7L2 in cyclin D2 and Bmp4 expression and cardiomyocyte cell cycle control during late heart development","volume":"99","author":"Ye","year":"2019","journal-title":"Lab. Investig."},{"issue":"17","key":"10.1016\/j.intimp.2026.117218_bb0185","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.21037\/atm-21-3127","article-title":"ACY1 regulating PTEN\/PI3K\/AKT signaling in the promotion of non-small cell lung cancer progression","volume":"9","author":"Chen","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"9","key":"10.1016\/j.intimp.2026.117218_bb0190","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2026.117218_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002206","article-title":"Chronic therapy with elamipretide (MTP-131), a novel mitochondria-targeting peptide, improves left ventricular and mitochondrial function in dogs with advanced heart failure","volume":"9","author":"Sabbah","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.intimp.2026.117218_bb0200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.redox.2017.02.012","article-title":"Mitochondrial composition and function under the control of hypoxia","volume":"12","author":"Fuhrmann","year":"2017","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117218_bb0205","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0008-6363(99)00027-9","article-title":"Respiratory control in normal and hypertrophic hearts","volume":"42","author":"Gibbs","year":"1999","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.intimp.2026.117218_bb0210","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","article-title":"Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis","volume":"126","author":"Tian","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117218_bb0215","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s12276-025-01446-9","article-title":"Phospholipase D6 activates Wnt\/\u03b2-catenin signaling through mitochondrial metabolic reprogramming to promote tumorigenesis in colorectal cancer","volume":"57","author":"Lee","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117218_bb0220","first-page":"15","article-title":"The WNT\/\u03b2-catenin pathway regulates expression of the genes involved in cell cycle progression and mitochondrial oxidative phosphorylation in the postmitotic cardiac myocytes","volume":"2","author":"Olcum","year":"2022","journal-title":"J. Cardiovasc. Aging."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:00:51Z","timestamp":1789142451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"alternative-id":["S1567576926010647"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117218","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac ACY1 ameliorates pathological hypertrophy by suppressing \u03b2-catenin\/TCF4 signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117218"}}